Multidrug-resistant organisms in patients from Ukraine in the Netherlands, March to August 2022

Romy D. Zwittink, Cornelia C.H. Wielders, The Dutch CPE and MRSA Surveillance Study Groups, Daan W. Notermans, Nelianne J. Verkaik, Annelot F. Schoffelen, Sandra Witteveen, Varisha A. Ganesh, Angela De Haan, Jeroen Bos, Jacinta Bakker, Caroline Schneeberger Van Der Linden, Ed J. Kuijper, Sabine C. De Greeff, Antoni P.A. Hendrickx*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

8 Citations (Scopus)
63 Downloads (Pure)


Since March 2022, there has been an emergence of multidrug-resistant organisms (MDRO) in the Netherlands in patients originating from Ukraine (58 patients, 75 isolates). For about half of these patients, recent hospitalisation in Ukraine was reported. Genomic surveillance revealed that the majority of the MDRO represent globally spread epidemic lineages and that 60% contain New Delhi metallo-β-lactamase (NDM) genes. Professionals should be aware of an increase in such MDRO associated with migration and medical evacuation of people from Ukraine.

Original languageEnglish
Article number2200896
Issue number50
Publication statusPublished - 15 Dec 2022

Bibliographical note

Funding Information:
This study was carried out as part of the Dutch National CPE and MRSA surveillance, as part of the regular activities of the RIVM, financed by the Dutch Ministry of Health, Welfare and Sport.

Publisher Copyright:
© 2022 European Centre for Disease Prevention and Control (ECDC). All rights reserved.


Dive into the research topics of 'Multidrug-resistant organisms in patients from Ukraine in the Netherlands, March to August 2022'. Together they form a unique fingerprint.

Cite this